Altis Labs, whose AI model analyzes CT scans taken during oncology trials and produces predictions tied to patient survival, has raised a $25M Series A (Natalie Breymeyer/Axios)

Altis Labs 完成 2500 万美元 A 轮融资,其 AI 模型可以分析肿瘤临床试验中拍摄的 CT 影像,并输出与患者生存期相关的预测结果。这类“影像+预后”的医疗 AI 正在从科研概念走向可被资本和药企验证的商业产品。








